Clinical Trial Update: To Evaluate the Efficacy and Safety of DW-1401 in Acute and Chronic Gastritis Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update for DW-1401 evaluating efficacy and safety in acute and chronic gastritis. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastritis

Drugs mentioned

• DW-1401

Snippet

Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Gastritis Acute, Gastritis Chronic | Phase 3 | Status: COMPLETED